Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novartis To Launch Six New Drugs In China

This article was originally published in PharmAsia News

Executive Summary

Novartis says it plans to launch six new drugs in China this year in an effort to boost the nation's share of Novartis sales beyond the current 1 percent. As part of its plans in China, Novartis says it will increase its local staff by 20 percent this year, bucking the trend of most other multinational companies of reducing staff. The Novartis plan envisions increasing global sales by 5 percent this year and is counting on China to help achieve that goal. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071108

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel